Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
Adults with treatment-resistant major depression who received intravenous ketamine twice a week for three weeks improved at ...
Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...